StockData
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Personalis, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$15.88+0.23 (+1.47%)

Close on Oct 19, 2026

Market cap
$1.67B
P/E (TTM)
–
Dividend yield
–

Personalis, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Personalis does not break out revenue by segment, region or product in the tagged data of its filings for this period type.